USA Latent Tuberculosis Infection (LTBI) Testing Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Latent Tuberculosis Infection (LTBI) Testing market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Latent Tuberculosis Infection (LTBI) Testing market. Detailed analysis of key players, along with key growth strategies adopted by Latent Tuberculosis Infection (LTBI) Testing industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Danaher

    • Becton Dickinson

    • BioMerieux

    • Bio-Rad Laboratories

    • Qiagen

    • Eppendorf

    • Thermo Fisher Scientific

    • Roche

    • Abbott Laboratories

    • Agilent Technologies

    By Type:

    • Tuberculin Skin Test (TST)

    • Interferon Gamma Released Assay (IGRA)

    • Others

    By End-User:

    • Household Contacts with Pulmonary TB

    • PLHIV

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Latent Tuberculosis Infection (LTBI) Testing Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate of Tuberculin Skin Test (TST) from 2016 to 2027

      • 1.3.2 USA Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate of Interferon Gamma Released Assay (IGRA) from 2016 to 2027

      • 1.3.3 USA Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate of Household Contacts with Pulmonary TB from 2016 to 2027

      • 1.4.2 USA Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate of PLHIV from 2016 to 2027

      • 1.4.3 USA Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Latent Tuberculosis Infection (LTBI) Testing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Latent Tuberculosis Infection (LTBI) Testing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Latent Tuberculosis Infection (LTBI) Testing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Latent Tuberculosis Infection (LTBI) Testing Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Latent Tuberculosis Infection (LTBI) Testing Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Latent Tuberculosis Infection (LTBI) Testing by Major Types

      • 3.4.1 Market Size and Growth Rate of Tuberculin Skin Test (TST)

      • 3.4.2 Market Size and Growth Rate of Interferon Gamma Released Assay (IGRA)

      • 3.4.3 Market Size and Growth Rate of Others

    4 Segmentation of Latent Tuberculosis Infection (LTBI) Testing Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Latent Tuberculosis Infection (LTBI) Testing by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Latent Tuberculosis Infection (LTBI) Testing in Household Contacts with Pulmonary TB

      • 4.4.2 Market Size and Growth Rate of Latent Tuberculosis Infection (LTBI) Testing in PLHIV

      • 4.4.3 Market Size and Growth Rate of Latent Tuberculosis Infection (LTBI) Testing in Others

    5 Market Analysis by Regions

    • 5.1 USA Latent Tuberculosis Infection (LTBI) Testing Production Analysis by Regions

    • 5.2 USA Latent Tuberculosis Infection (LTBI) Testing Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Latent Tuberculosis Infection (LTBI) Testing Landscape Analysis

    • 6.1 West USA Latent Tuberculosis Infection (LTBI) Testing Landscape Analysis by Major Types

    • 6.2 West USA Latent Tuberculosis Infection (LTBI) Testing Landscape Analysis by Major End-Users

    7 South USA Latent Tuberculosis Infection (LTBI) Testing Landscape Analysis

    • 7.1 South USA Latent Tuberculosis Infection (LTBI) Testing Landscape Analysis by Major Types

    • 7.2 South USA Latent Tuberculosis Infection (LTBI) Testing Landscape Analysis by Major End-Users

    8 Middle West USA Latent Tuberculosis Infection (LTBI) Testing Landscape Analysis

    • 8.1 Middle West USA Latent Tuberculosis Infection (LTBI) Testing Landscape Analysis by Major Types

    • 8.2 Middle West USA Latent Tuberculosis Infection (LTBI) Testing Landscape Analysis by Major End-Users

    9 Northeast USA Latent Tuberculosis Infection (LTBI) Testing Landscape Analysis

    • 9.1 Northeast USA Latent Tuberculosis Infection (LTBI) Testing Landscape Analysis by Major Types

    • 9.2 Northeast USA Latent Tuberculosis Infection (LTBI) Testing Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Danaher

        • 10.1.1 Danaher Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Becton Dickinson

        • 10.2.1 Becton Dickinson Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 BioMerieux

        • 10.3.1 BioMerieux Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Bio-Rad Laboratories

        • 10.4.1 Bio-Rad Laboratories Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Qiagen

        • 10.5.1 Qiagen Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Eppendorf

        • 10.6.1 Eppendorf Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Thermo Fisher Scientific

        • 10.7.1 Thermo Fisher Scientific Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Roche

        • 10.8.1 Roche Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Abbott Laboratories

        • 10.9.1 Abbott Laboratories Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Agilent Technologies

        • 10.10.1 Agilent Technologies Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate of Tuberculin Skin Test (TST) from 2016 to 2027

    • Figure USA Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate of Interferon Gamma Released Assay (IGRA) from 2016 to 2027

    • Figure USA Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate of Household Contacts with Pulmonary TB from 2016 to 2027

    • Figure USA Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate of PLHIV from 2016 to 2027

    • Figure USA Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Latent Tuberculosis Infection (LTBI) Testing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Latent Tuberculosis Infection (LTBI) Testing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Latent Tuberculosis Infection (LTBI) Testing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Latent Tuberculosis Infection (LTBI) Testing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Latent Tuberculosis Infection (LTBI) Testing Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Latent Tuberculosis Infection (LTBI) Testing

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Latent Tuberculosis Infection (LTBI) Testing by Different Types from 2016 to 2027

    • Table Consumption Share of Latent Tuberculosis Infection (LTBI) Testing by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Tuberculin Skin Test (TST)

    • Figure Market Size and Growth Rate of Interferon Gamma Released Assay (IGRA)

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Latent Tuberculosis Infection (LTBI) Testing by Different End-Users from 2016 to 2027

    • Table Consumption Share of Latent Tuberculosis Infection (LTBI) Testing by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Household Contacts with Pulmonary TB

    • Figure Market Size and Growth Rate of PLHIV

    • Figure Market Size and Growth Rate of Others

    • Table USA Latent Tuberculosis Infection (LTBI) Testing Production by Regions

    • Table USA Latent Tuberculosis Infection (LTBI) Testing Production Share by Regions

    • Figure USA Latent Tuberculosis Infection (LTBI) Testing Production Share by Regions in 2016

    • Figure USA Latent Tuberculosis Infection (LTBI) Testing Production Share by Regions in 2021

    • Figure USA Latent Tuberculosis Infection (LTBI) Testing Production Share by Regions in 2027

    • Table USA Latent Tuberculosis Infection (LTBI) Testing Consumption by Regions

    • Table USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by Regions

    • Figure USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by Regions in 2016

    • Figure USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by Regions in 2021

    • Figure USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by Regions in 2027

    • Table West USA Latent Tuberculosis Infection (LTBI) Testing Consumption by Types from 2016 to 2027

    • Table West USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by Types from 2016 to 2027

    • Figure West USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by Types in 2016

    • Figure West USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by Types in 2021

    • Figure West USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by Types in 2027

    • Table West USA Latent Tuberculosis Infection (LTBI) Testing Consumption by End-Users from 2016 to 2027

    • Table West USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by End-Users in 2016

    • Figure West USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by End-Users in 2021

    • Figure West USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by End-Users in 2027

    • Table South USA Latent Tuberculosis Infection (LTBI) Testing Consumption by Types from 2016 to 2027

    • Table South USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by Types from 2016 to 2027

    • Figure South USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by Types in 2016

    • Figure South USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by Types in 2021

    • Figure South USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by Types in 2027

    • Table South USA Latent Tuberculosis Infection (LTBI) Testing Consumption by End-Users from 2016 to 2027

    • Table South USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by End-Users in 2016

    • Figure South USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by End-Users in 2021

    • Figure South USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by End-Users in 2027

    • Table Middle West USA Latent Tuberculosis Infection (LTBI) Testing Consumption by Types from 2016 to 2027

    • Table Middle West USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by Types in 2016

    • Figure Middle West USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by Types in 2021

    • Figure Middle West USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by Types in 2027

    • Table Middle West USA Latent Tuberculosis Infection (LTBI) Testing Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by End-Users in 2016

    • Figure Middle West USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by End-Users in 2021

    • Figure Middle West USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by End-Users in 2027

    • Table Northeast USA Latent Tuberculosis Infection (LTBI) Testing Consumption by Types from 2016 to 2027

    • Table Northeast USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by Types in 2016

    • Figure Northeast USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by Types in 2021

    • Figure Northeast USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by Types in 2027

    • Table Northeast USA Latent Tuberculosis Infection (LTBI) Testing Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by End-Users in 2016

    • Figure Northeast USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by End-Users in 2021

    • Figure Northeast USA Latent Tuberculosis Infection (LTBI) Testing Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Danaher

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Danaher

    • Figure Sales and Growth Rate Analysis of Danaher

    • Figure Revenue and Market Share Analysis of Danaher

    • Table Product and Service Introduction of Danaher

    • Table Company Profile and Development Status of Becton Dickinson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Becton Dickinson

    • Figure Sales and Growth Rate Analysis of Becton Dickinson

    • Figure Revenue and Market Share Analysis of Becton Dickinson

    • Table Product and Service Introduction of Becton Dickinson

    • Table Company Profile and Development Status of BioMerieux

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioMerieux

    • Figure Sales and Growth Rate Analysis of BioMerieux

    • Figure Revenue and Market Share Analysis of BioMerieux

    • Table Product and Service Introduction of BioMerieux

    • Table Company Profile and Development Status of Bio-Rad Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bio-Rad Laboratories

    • Figure Sales and Growth Rate Analysis of Bio-Rad Laboratories

    • Figure Revenue and Market Share Analysis of Bio-Rad Laboratories

    • Table Product and Service Introduction of Bio-Rad Laboratories

    • Table Company Profile and Development Status of Qiagen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Qiagen

    • Figure Sales and Growth Rate Analysis of Qiagen

    • Figure Revenue and Market Share Analysis of Qiagen

    • Table Product and Service Introduction of Qiagen

    • Table Company Profile and Development Status of Eppendorf

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eppendorf

    • Figure Sales and Growth Rate Analysis of Eppendorf

    • Figure Revenue and Market Share Analysis of Eppendorf

    • Table Product and Service Introduction of Eppendorf

    • Table Company Profile and Development Status of Thermo Fisher Scientific

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific

    • Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific

    • Figure Revenue and Market Share Analysis of Thermo Fisher Scientific

    • Table Product and Service Introduction of Thermo Fisher Scientific

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories

    • Table Company Profile and Development Status of Agilent Technologies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agilent Technologies

    • Figure Sales and Growth Rate Analysis of Agilent Technologies

    • Figure Revenue and Market Share Analysis of Agilent Technologies

    • Table Product and Service Introduction of Agilent Technologies


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.